You searched for liver disease | Page 129 of 400

NATtrol Bacteriophage MS2 Launched by ZeptoMetrix

ZeptoMetrix, an Antylia Scientific company, launches the NATtrol Bacteriophage MS2 quantitative stock: NATMS2-STQ.

Posted by Chris Wolski | Nov 21, 2022 | Melanoma |

Roche has announced the launch of the PRAME Antibody to identify PRAME protein expression with suspected melanoma.

A new AI blood testing tech called DELFI successfully detected more than 80% of liver cancer cases in a new study.

NuraLogix has announced that its contactless health monitoring platform, Anura, will be able to assess metabolic and blood biomarker risks.

Posted by Andy Lundin | Nov 17, 2022 | Cardiovascular |

Clinicians who were high adopters of AI-enabled clinical decision support tools efficiently diagnosed low left ventricular ejection fraction.